ACUTUS MEDICAL, INC.
ACUTUS MEDICAL, INC.
CARLSBAD, CA
Loading...
Price History
Market Data
| Market Cap | 8,973.69 |
| P/E Ratio | - |
| P/B Ratio | - |
| EPS | -0.33 |
| Dividend Yield | - |
| D/E Ratio | - |
| Current Ratio | 2.06 |
| Currency | USD |
Key Financial Metrics
20.15M
Revenue
-9.55M
Net Income
-0.33
EPS (Diluted)
-72.85M
Free Cash Flow
Profitability
Gross Margin
5.0%
Operating Margin
-0.3%
Net Profit Margin
-47.4%
EBITDA
-66,000.00
Returns & Efficiency
Return on Assets (ROA)
-33.3%
Return on Equity (ROE)
-
Dividend Yield
-
EPS
-0.33
Financial Health
Total Assets
28.65M
Total Debt
25.56M
Debt to Equity
-
Current Ratio
2.06
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | CARLSBAD, CA |
| Fiscal Year | 2024 |
Peers
STRYKER CORP
SYK
113.24B
P/E: --
3M CO
MMM
86.42B
P/E: --
83.53B
P/E: --
41.26B
P/E: --
RESMED INC
RSMDF
37.64B
P/E: --
DEXCOM INC
DXCM
22.94B
P/E: --
21.69B
P/E: 35.1
PENUMBRA INC
PEN
12.76B
P/E: 85.5
Quick Links
Financial Statistics
Valuation
Market Cap$8.97K
P/E Ratio (TTM)-
Price to Book-
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin5.0%
Operating Margin-0.3%
Net Margin-47.4%
ROE-
ROA-33.3%
Leverage & Liquidity
Debt to Equity-
Current Ratio2.06
Total Debt$25.56M
Total Assets$28.65M
Stockholders' Equity$-11.59M
Income Statement (FY 2024)
Revenue$20.15M
Gross Profit$1.00M
Operating Income$-66.00K
Net Income$-9.55M
EPS (Diluted)$-0.33
Cash Flow (FY 2024)
Free Cash Flow$-72.85M
Cash & Equivalents$14.02M
Revenue Growth-0.0%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 2210 FARADAY AVE SUITE 100 CARLSBAD, CA 92008 |
| Phone | 442-232-6080 |
| Incorporated | DE, US |
| EIN | 451306615 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 29.91M |
| Stockholders' Equity | $-11.59M |
| Cash & Equivalents | $14.02M |
Recent Filings
View All
SCHEDULE 13G/A
Amended Schedule 13G
Amendment to Schedule 13G
Filed: 2026-02-17
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2025-03-24
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-11-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-08-08
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2024-05-09
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2024-04-25
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2024-04-01
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-11-14
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-08-07
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2023-05-11
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2023-04-27
Local
10-K
Annual Report
Comprehensive annual financial report with audited statements
Filed: 2023-03-24
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-11-10
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-08-11
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2022-05-12
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | ACUTUS MEDICAL, INC. |
| Ticker | AFIB |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | CARLSBAD, CA |
| Fiscal Year | 2024 |
Financial Summary
| Market Cap | 8,973.69 |
| Revenue | 20.15M |
| Net Income | -9.55M |
| P/E Ratio | - |
| EPS | -0.33 |
| Net Margin | -47.4% |
| ROE | - |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...